Twist Bioscience Corp vs State Street Technology Select Sector SPDR ETF — how do they compare? Twist Bioscience Corp trades at $88.31 (market cap $5.45B), while State Street Technology Select Sector SPDR ETF trades at $180.7. Which is the better fit depends on your goals.
| TWST | XLK | |
|---|---|---|
Market Cap | $5.45B | — |
Sector | Health | Sector/Thematic |
52-Week High | $102.88 | $198.21 |
52-Week Low | $24.16 | $127.49 |
Enterprise Value | $5.37B | — |
Trailing returns across standard periods
Latest headlines on both assets
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →XLK tracks the Technology Select Sector Index, providing targeted exposure to the largest and most influential technology companies within the S&P 500. It is a highly concentrated, liquid vehicle focused on software, semiconductors, and hardware leaders, serving as the primary benchmark for U.S. large-cap technology performance.
Read more on XLK →